EUVIMED · CrossrefJournal
Intestinal Research
ISSN 1598-9100 · Korean Association for the Study of Intestinal Diseases
Latest articles
Clinical profiles and management strategies in older adults with mild-to-moderate ulcerative colitis: a multicenter, comparative, real-world study
The role of the Mediterranean diet in the management of inflammatory bowel disease: a narrative review
The impact of inflammatory bowel disease on women’s health: a cross-sectional study in India
Diagnosis of intestinal tuberculosis: a systematic review and meta-analysis
First-line biologic therapy selection highly impacts ulcerative colitis outcomes: results from the APPETISER study
Colitis-associated colorectal neoplasia in ulcerative colitis with primary sclerosing cholangitis: a nationwide study
Evaluation of the Mayo endoscopic score in ulcerative colitis using a multimodal large language model: a human-blinded accuracy study
Efficacy and safety of filgotinib in the treatment of ulcerative colitis with a focus on rapid and sustained efficacy: a narrative review
Safety and effectiveness of budesonide rectal foam for ulcerative colitis in a large-scale, multicenter, prospective observational study: final report of post-marketing surveillance in Japan
Efficacy and safety of mirikizumab in maintenance therapy for ulcerative colitis in difficult-to-treat inflammatory bowel disease: a single-center retrospective study in Japan
Impact of Portulaca oleracea L. extract in patients with irritable bowel syndrome
Clinical usefulness of fecal calprotectin in assessing disease activity and endoscopic remission in intestinal Behçet’s disease
Biology and preclinical models of colorectal cancer metastasis
Integrated endoscopic and medical approaches for Crohn’s disease-associated strictures
Comments on “Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study”
Chinese expert consensus on extraintestinal manifestations of inflammatory bowel disease
Primary sclerosing cholangitis and ulcerative colitis-associated neoplasia in Asia: optimizing beyond risk recognition
Beyond first-line biologic therapy: does treatment sequence matter in ulcerative colitis?
Comparative outcomes for tirzepatide versus glucagon-like peptide-1 receptor agonists in patients with inflammatory bowel disease: a national propensity matched study
Real-world data on the effectiveness of risankizumab as induction therapy for ustekinumab-refractory ulcerative colitis
Gut microbiome: a key driver and therapeutic target of intestinal fibrosis in Crohn’s disease
Evidence-based clinical practice guidelines for diagnosis and medical management of acute colonic diverticulitis developed by the Korean Association for the Study of Intestinal Diseases (KASID)
Venous thromboembolism prophylaxis in pregnant women with inflammatory bowel disease: evidence gaps and future directions from the KASID Guidelines Task Force Team
Anti-tumor necrosis factor-α therapy and paradoxical autoimmunity in inflammatory bowel disease: a need for risk-aware monitoring
Upadacitinib in Asian inflammatory bowel disease practice: encouraging real-world efficacy
Transabdominal ultrasonography for small-bowel lesions in Crohn’s disease: a prospective comparison with balloon-assisted enteroscopy
Long-term efficacy and safety of vedolizumab compared with infliximab in biologic-naive ulcerative colitis: a systematic review and meta-analysis
Environmental pollutants and the rising burden of inflammatory bowel disease in East Asia: a narrative review
Efficacy and safety of ustekinumab in Asian patients with moderately to severely active Crohn’s disease: a small subpopulation analysis of UNITI/IM-UNITI long-term extension through 5 years
Efficacy and safety of ozanimod in Japanese patients with moderately to severely active ulcerative colitis naive to immunomodulators or advanced therapies: post hoc analysis of the phase 2/3 J-True North study
EUVIMED